Is GNFTF or RYLD a better dividend investment in 2026?

GNFTF currently yields 19.18% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: GNFTF offers higher current income.

What is the dividend yield difference between GNFTF and RYLD?

GNFTF has a forward dividend yield of 19.18% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 6.79 percentage points.

Home › Compare › GNFTF vs RYLD

GNFTF vs RYLD: Dividend Comparison 2026

GNFTF yields 19.18% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GNFTF wins by $24.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

GNFTF

● Live price

19.18%

Share price

$10.43

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$69.4K

Annual income

$6,165.13

Full GNFTF calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — GNFTF vs RYLD

📍 GNFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GNFTF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GNFTF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GNFTF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNFTF

Annual income on $10K today (after 15% tax)

$1,629.91/yr

After 10yr DRIP, annual income (after tax)

$5,240.36/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, GNFTF beats the other by $2,959.83/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNFTF + RYLD for your $10,000?

GNFTF: 50%RYLD: 50%

100% RYLD50/50100% GNFTF

Portfolio after 10yr

$57.3K

Annual income

$4,424.06/yr

Blended yield

7.72%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GNFTF right now

GNFTF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

0.2

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNFTF buys

RYLD buys

No recent congressional trades found for GNFTF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGNFTFRYLD

Forward yield	19.18% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$69.4K ✓	$45.3K
Annual income after 10y	$6,165.13 ✓	$2,682.98
Total dividends collected	$38.6K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: GNFTF vs RYLD ($10,000, DRIP)

Year	GNFTF Portfolio	GNFTF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$12,618	$1,917.55	$11,939	$1,239.34	+$679.00 → GNFTF
2	$15,762	$2,261.19	$14,158	$1,382.89	+$1.6K → GNFTF
3	$19,505	$2,639.91	$16,682	$1,532.59	+$2.8K → GNFTF
4	$23,924	$3,053.13	$19,537	$1,687.64	+$4.4K → GNFTF
5	$29,098	$3,499.76	$22,752	$1,847.20	+$6.3K → GNFTF
6	$35,113	$3,978.25	$26,355	$2,010.43	+$8.8K → GNFTF
7	$42,058	$4,486.56	$30,376	$2,176.45	+$11.7K → GNFTF
8	$50,024	$5,022.33	$34,847	$2,344.43	+$15.2K → GNFTF
9	$59,109	$5,582.83	$39,800	$2,513.54	+$19.3K → GNFTF
10	$69,411	$6,165.13	$45,269	$2,682.98	+$24.1K → GNFTF

GNFTF vs RYLD: Complete Analysis 2026

GNFTF — Stock

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Full GNFTF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this GNFTF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNFTF vs SCHD GNFTF vs JEPI GNFTF vs O GNFTF vs KO GNFTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.